Phase II investigator-sponsored trial of single-agent palifosfamide in patients with recurrent metastatic germ cell cancer who have relapsed after initial platinum-based therapy and high-dose chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 11 Mar 2013
At a glance
- Drugs Palifosfamide (Primary)
- Indications Germ cell and embryonal neoplasms; Ovarian cancer; Testicular cancer
- Focus Therapeutic Use
- 11 Mar 2013 New trial record